Evaluation of the Extension at Community Level of Safe Male Circumcision (ANRS 12126 ORANGE FARM 2)

NCT00623051 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27000

Last updated 2013-07-17

No results posted yet for this study

Summary

This study is aimed at demonstrating whether or not Male Circumcision can be used as an effective public health prevention tool that will have an impact on HIV prevalence in the South African population.

Conditions

  • HIV Infections

Interventions

PROCEDURE

Male Circumcision

Sponsors & Collaborators

  • French National Agency for Research on AIDS and Viral Hepatitis

    lead OTHER_GOV

Principal Investigators

  • Bertran Auvert, MD, PhD · University of Versailles, INSERM U687, France

  • David Lewis, MD · NICD, Johannesburg

  • Mohamed Haffejee, MD · Wits Medical School, Urology Department, Johannesburg

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • South Africa

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00623051 on ClinicalTrials.gov